• Je něco špatně v tomto záznamu ?

Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study

R. Ciccocioppo, S. Bozzini, E. Betti, V. Imbesi, C. Klersy, LS. Lakyova, L. Sukovsky, J. Benacka, P. Kruzliak, GR. Corazza, A. Di Sabatino, C. Falcone,

. 2019 ; 19 (3) : 367-375. [pub] 20190607

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044772

The receptor for the advanced glycation end products (RAGE) is a multiligand transmembrane receptor involved in chronic inflammation whose specific polymorphisms of the promoter gene were found to increase its transcriptional activity. We investigated the association of both allelic and genotypic -374T/A and -429T/C polymorphisms with inflammatory bowel disease. The STREGA guidelines were applied for planning and reporting. We enrolled 133 patients with Crohn's disease (CD), 149 with ulcerative colitis (UC), and 128 blood donors. Genomic DNA was extracted from peripheral blood leukocytes collected from each patient and control. RAGE polymorphisms were analyzed by PCR-restriction fragment length polymorphism assay. The Hardy-Weinberg equilibrium was first assessed, and then, the Kruskal-Wallis test and the Fisher exact test were used for etiologic group comparisons. Distribution of patients' characteristics across genotypes was evaluated by the Fisher exact test, while that across alleles was analyzed with a probit model. A 2-sided value of p < 0.05 was considered significant. Following the evidence of the Hardy-Weinberg equilibrium, we found a higher prevalence of the allele A of the -374T/A haplotype in UC (p = 0.043), and of the allele C of the -429T/C haplotype in CD (p < 0.001) with respect to the other groups. Moreover, the homozygous AA genotype of the -374T/A polymorphism resulted associated with late onset of CD, while its TT genotype with early onset (p = 0.049). The allele C of the 429T/C haplotype was associated with early onset of UC (p = 0.03), while a higher frequency of the heterozygous TC haplotype was found in those with pancolitis (p = 0.026). The differing distribution of these polymorphisms in healthy donors and CD/UC patients suggests a role in the development and outcome of these pathological conditions.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044772
003      
CZ-PrNML
005      
20200113110107.0
007      
ta
008      
200109s2019 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10238-019-00562-x $2 doi
035    __
$a (PubMed)31175506
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Ciccocioppo, Rachele $u Gastroenterology Unit, Department of Medicine, AOUI Policlinico G.B. Rossi and University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. rachele.ciccocioppo@univr.it.
245    10
$a Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study / $c R. Ciccocioppo, S. Bozzini, E. Betti, V. Imbesi, C. Klersy, LS. Lakyova, L. Sukovsky, J. Benacka, P. Kruzliak, GR. Corazza, A. Di Sabatino, C. Falcone,
520    9_
$a The receptor for the advanced glycation end products (RAGE) is a multiligand transmembrane receptor involved in chronic inflammation whose specific polymorphisms of the promoter gene were found to increase its transcriptional activity. We investigated the association of both allelic and genotypic -374T/A and -429T/C polymorphisms with inflammatory bowel disease. The STREGA guidelines were applied for planning and reporting. We enrolled 133 patients with Crohn's disease (CD), 149 with ulcerative colitis (UC), and 128 blood donors. Genomic DNA was extracted from peripheral blood leukocytes collected from each patient and control. RAGE polymorphisms were analyzed by PCR-restriction fragment length polymorphism assay. The Hardy-Weinberg equilibrium was first assessed, and then, the Kruskal-Wallis test and the Fisher exact test were used for etiologic group comparisons. Distribution of patients' characteristics across genotypes was evaluated by the Fisher exact test, while that across alleles was analyzed with a probit model. A 2-sided value of p < 0.05 was considered significant. Following the evidence of the Hardy-Weinberg equilibrium, we found a higher prevalence of the allele A of the -374T/A haplotype in UC (p = 0.043), and of the allele C of the -429T/C haplotype in CD (p < 0.001) with respect to the other groups. Moreover, the homozygous AA genotype of the -374T/A polymorphism resulted associated with late onset of CD, while its TT genotype with early onset (p = 0.049). The allele C of the 429T/C haplotype was associated with early onset of UC (p = 0.03), while a higher frequency of the heterozygous TC haplotype was found in those with pancolitis (p = 0.026). The differing distribution of these polymorphisms in healthy donors and CD/UC patients suggests a role in the development and outcome of these pathological conditions.
650    _2
$a dospělí $7 D000328
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a frekvence genu $7 D005787
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genotyp $7 D005838
650    _2
$a genotypizační techniky $7 D060005
650    _2
$a lidé $7 D006801
650    _2
$a idiopatické střevní záněty $x genetika $7 D015212
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a polymorfismus délky restrikčních fragmentů $7 D012150
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a prevalence $7 D015995
650    12
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a receptor pro konečné produkty pokročilé glykace $x genetika $7 D000067759
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bozzini, Sara $u Interdipartimental Center for the Molecular Medicine Research and Cardiology Unit, Istituto di Cura Città di Pavia and University of Pavia, Pavia, Italy.
700    1_
$a Betti, Elena $u Clinica Medica I, Department of Internal Medicine and Therapeutics, I.R.C.C.S. Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
700    1_
$a Imbesi, Venerina $u Gastroenterology and Digestive Endoscopy Unit, Legnano Hospital, ASST Ovest Milanese, Legnano, Italy.
700    1_
$a Klersy, Catherine $u Service of Clinical Epidemiology and Biostatistics, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.
700    1_
$a Lakyova, Lucia Sukovska $u 1st Department of Surgery, Faculty of Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital, Trieda SNP1, 040 11, Kosice, Slovakia. lucia.lakyova@upjs.sk.
700    1_
$a Sukovsky, Lukas $u 1st Department of Surgery, Faculty of Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital, Trieda SNP1, 040 11, Kosice, Slovakia.
700    1_
$a Benacka, Jozef $u Faculty of Health and Social Work, Trnava University, Trnava, Slovakia.
700    1_
$a Kruzliak, Peter $u Department of Internal Medicine, Brothers of Mercy Hospital, Polni 3, 63900, Brno, Czech Republic. kruzliakpeter@gmail.com. 2nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic. kruzliakpeter@gmail.com.
700    1_
$a Corazza, Gino Roberto $u Clinica Medica I, Department of Internal Medicine and Therapeutics, I.R.C.C.S. Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
700    1_
$a Di Sabatino, Antonio $u Clinica Medica I, Department of Internal Medicine and Therapeutics, I.R.C.C.S. Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
700    1_
$a Falcone, Colomba $u Interdipartimental Center for the Molecular Medicine Research and Cardiology Unit, Istituto di Cura Città di Pavia and University of Pavia, Pavia, Italy.
773    0_
$w MED00006222 $t Clinical and experimental medicine $x 1591-9528 $g Roč. 19, č. 3 (2019), s. 367-375
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31175506 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113110439 $b ABA008
999    __
$a ok $b bmc $g 1483041 $s 1083445
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 19 $c 3 $d 367-375 $e 20190607 $i 1591-9528 $m Clinical and Experimental Medicine $n Clin Exp Med $x MED00006222
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...